APYX Key Statistics, Chart & Performance
The current stock price of APYX is 3.87 USD. In the past month the price increased by 7.5%. In the past year, price increased by 168.75%.
APYX Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to APYX. When comparing the yearly performance of all stocks, APYX is one of the better performing stocks in the market, outperforming 96.69% of all stocks.
APYX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to APYX. APYX may be in some trouble as it scores bad on both profitability and health.
APYX Financial Highlights
Over the last trailing twelve months APYX reported a non-GAAP Earnings per Share(EPS) of -0.36. The EPS increased by 56.63% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -25.35% | ||
| ROE | -248.63% | ||
| Debt/Equity | 5.92 |
APYX Forecast & Estimates
11 analysts have analysed APYX and the average price target is 5.87 USD. This implies a price increase of 51.55% is expected in the next year compared to the current price of 3.87.
For the next year, analysts expect an EPS growth of 52.43% and a revenue growth 9.08% for APYX
APYX Ownership
About APYX
Company Profile
Apyx Medical Corp. operates as an energy-based medical technology company. The company is headquartered in Clearwater, Florida and currently employs 220 full-time employees. Its segments include Advanced Energy and Original Equipment Manufacturer (OEM). The Advanced Energy segment’s product portfolio consists of its Helium Plasma Technology that is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. The company focuses on the cosmetic surgery market, where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. These product lines consist of a multifunction generator, a handpiece and a supply of helium gas. Through OEM agreements, the OEM segment, designs, develops and manufactures electrosurgical equipment and medical devices by producing generators, medical devices and related accessories for medical device manufacturers as well as start-up businesses in need of its energy-based designs.
Company Info
APYX MEDICAL CORP
5115 Ulmerton Road
Clearwater FLORIDA 33760 US
CEO: Charles D. Goodwin II
Employees: 220
Phone: 17273842323
APYX MEDICAL CORP / APYX FAQ
Can you describe the business of APYX MEDICAL CORP?
Apyx Medical Corp. operates as an energy-based medical technology company. The company is headquartered in Clearwater, Florida and currently employs 220 full-time employees. Its segments include Advanced Energy and Original Equipment Manufacturer (OEM). The Advanced Energy segment’s product portfolio consists of its Helium Plasma Technology that is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. The company focuses on the cosmetic surgery market, where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. These product lines consist of a multifunction generator, a handpiece and a supply of helium gas. Through OEM agreements, the OEM segment, designs, develops and manufactures electrosurgical equipment and medical devices by producing generators, medical devices and related accessories for medical device manufacturers as well as start-up businesses in need of its energy-based designs.
What is the current price of APYX stock?
The current stock price of APYX is 3.87 USD. The price decreased by -2.52% in the last trading session.
Does APYX stock pay dividends?
APYX does not pay a dividend.
What is the ChartMill rating of APYX MEDICAL CORP stock?
APYX has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the Price/Earnings (PE) ratio of APYX MEDICAL CORP (APYX)?
APYX MEDICAL CORP (APYX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.36).
What is the next earnings date for APYX stock?
APYX MEDICAL CORP (APYX) will report earnings on 2026-03-11, after the market close.
What is the outstanding short interest for APYX MEDICAL CORP?
The outstanding short interest for APYX MEDICAL CORP (APYX) is 0.32% of its float.